de Souza, Savia
Williams, Ruth
Nikiphorou, Elena
Funding for this research was provided by:
Pfizer (63197191)
Article History
Received: 7 February 2023
Accepted: 21 December 2023
First Online: 17 January 2024
Declarations
:
: Ethics approval was granted by UK National Health Service Health Research Authority Health and Social Care Research Ethics Committee A (reference number: 21/NI/0111). Completion of surveys implied consent and written informed consent was obtained for all patient interviewees and focus group participants.
: Not applicable.
: SdS: None; RW: None; EN: has received honoraria and speaker’s fees from Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, Lilly, and grant/research support from Pfizer and Lilly.